Clinical Trial Update: Maternal Serum Markers Predicting Preeclampsia At Early Gestations

View source ↗

Summary

This completed clinical trial evaluated maternal serum biomarkers to predict preeclampsia at early gestation. The sponsor is HBI Solutions Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia
• Preterm Birth

Snippet

Sponsor: HBI Solutions Inc. | Conditions: Pre-eclampsia, Preterm Birth | Status: COMPLETED